Featured Research

from universities, journals, and other organizations

Clinical trials with nonblinded outcome assessors have high observer bias

Date:
January 28, 2013
Source:
Canadian Medical Association Journal
Summary:
A new study of randomized clinical trials found significant observer bias toward a more beneficial treatment effect in nonblinded trials when the researcher knew the treatment being given to the participant.

A new study of randomized clinical trials found significant observer bias toward a more beneficial treatment effect in nonblinded trials when the researcher knew the treatment being given to the participant. The study is published in CMAJ (Canadian Medical Association Journal).

Related Articles


"Nonblinded assessors of subjective measurement scales outcomes in randomized clinical trials tended to generate substantially biased effect sizes," writes Dr. Asbjørn Hróbjartsson, The Nordic Cochrane Centre, Rigshospitalet Department, Copenhagen, Denmark, with coauthors.

Danish and French researchers conducted a systematic review of 24 randomized clinical trials with both blinded and nonblinded assessment of the treatment effects. This design enabled a direct and reliable comparison between blind and nonblind results. Sixteen trials (with 2854 patients) had subjective outcomes and were included in the final meta-analysis. Neurology, cosmetic surgery, cardiology, psychiatry, otolaryngology, dermatology, gynecology and infectious diseases were all represented.

"In some trials, conscientious nonblinded assessors may overcompensate for an expected bias in favour of the experimental intervention and paradoxically induce a bias favouring the control, whereas other trials will have fairly neutral assessors with no important bias. Thus, the degree of observer bias in trials with clearly predisposed outcome assessors is likely to be considerably higher than the mean we see here," write the authors. They suggest using blinded assessors in trials to remove this bias.

"Failure to blind outcome assessors in such trials results in a high risk of substantial bias," conclude the authors.


Story Source:

The above story is based on materials provided by Canadian Medical Association Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. Asbjørn Hróbjartsson, Ann Sofia Skou Thomsen, Frida Emanuelsson, Britta Tendal, Jørgen Hilden, Isabelle Boutron, Philippe Ravaud, Stig Brorson. Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. CMAJ, 2013 DOI: 10.1503/cmaj.120744

Cite This Page:

Canadian Medical Association Journal. "Clinical trials with nonblinded outcome assessors have high observer bias." ScienceDaily. ScienceDaily, 28 January 2013. <www.sciencedaily.com/releases/2013/01/130128133856.htm>.
Canadian Medical Association Journal. (2013, January 28). Clinical trials with nonblinded outcome assessors have high observer bias. ScienceDaily. Retrieved October 26, 2014 from www.sciencedaily.com/releases/2013/01/130128133856.htm
Canadian Medical Association Journal. "Clinical trials with nonblinded outcome assessors have high observer bias." ScienceDaily. www.sciencedaily.com/releases/2013/01/130128133856.htm (accessed October 26, 2014).

Share This



More Science & Society News

Sunday, October 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Microsoft Riding High On Strong Surface, Cloud Performance

Microsoft Riding High On Strong Surface, Cloud Performance

Newsy (Oct. 24, 2014) — Microsoft's Q3 earnings showed its tablets and cloud services are really hitting their stride. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Science & Society

Business & Industry

Education & Learning

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins